Study uncovers shocking truth after stopping weight loss drugs

The Surprising Consequences of Stopping Weight Loss Medications

A recent study has uncovered a concerning phenomenon: when individuals stop taking popular weight loss medications like Ozempic and Wegovy, their bodies may experience a dramatic and unexpected response. This outcome is something many users did not anticipate, raising important questions about the long-term effectiveness of these drugs.

Ozempic and Wegovy have gained widespread popularity as go-to options for rapid weight loss. Many high-profile individuals, including celebrities, have openly shared their experiences with these medications. These injectable drugs are primarily designed to manage type 2 diabetes by helping the brain regulate feelings of fullness. However, they have become increasingly popular for off-label use in weight management.

While Wegovy is FDA-approved for weight management, Ozempic is only approved for treating type 2 diabetes. This distinction highlights the need for caution and proper medical guidance when using these medications for weight loss purposes.

Uncovering the Long-Term Effects

Despite their popularity, the long-term sustainability of these medications is now being questioned. A recent analysis found that most users stop taking them within two years and experience significant weight gain afterward. A 2025 study conducted by Han Wu and Wenjia Yang at Peking University People’s Hospital in China explored what happens after discontinuation of anti-obesity medications (AOMs).

The study involved 11 clinical trials with 2,466 participants who had been on medications such as Ozempic and Wegovy for at least four weeks. Researchers observed the participants for another four to five months after treatment ended. The findings were striking: participants initially maintained some weight loss but only for a few weeks. By week eight, weight regain was noticeable compared to those who had never used the drugs. After three to five months, the weight gain continued and even worsened, with the largest rebound seen in those who had taken the medications.

Withdrawal and Weight Regain

This issue is not new. A 2022 study published in the National Library of Medicine found similar results. The clinical trial followed around 200 participants who had taken semaglutide (the active ingredient in Wegovy and Ozempic) for over a year, losing an average of 17% of their body weight. When some of them stopped the medication, they regained about 12% of their weight within just one year. While they still maintained a net 5% weight loss, this result raises concerns about the long-term viability of weight loss with semaglutide.

The study concluded that among adults with overweight or obesity, after achieving significant weight loss with semaglutide and lifestyle changes, most of the weight was regained within one year after stopping the treatment.

Managing Weight After Treatment Ends

Medical News Today warns that the return of appetite to pretreatment levels can lead to weight regain. Adding other lifestyle changes to Ozempic treatment can help manage weight after treatment ends. However, even with a healthy lifestyle, there is still a chance of regaining some weight after stopping the medication. On average, people may regain up to two-thirds of their prior weight loss.

While these drugs can be life-changing for individuals with conditions like diabetes or severe obesity, the findings suggest they may not be a long-term solution for weight loss alone. For those hoping to lose weight quickly and then stop treatment, the risk of weight regain remains a significant concern.

Ozempic and similar drugs may help melt away pounds, but once treatment stops, the weight could return. This highlights the importance of considering long-term strategies for maintaining a healthy weight.